WO2003000202A3 - Particles for inhalation having rapid release properties - Google Patents

Particles for inhalation having rapid release properties Download PDF

Info

Publication number
WO2003000202A3
WO2003000202A3 PCT/US2002/020280 US0220280W WO03000202A3 WO 2003000202 A3 WO2003000202 A3 WO 2003000202A3 US 0220280 W US0220280 W US 0220280W WO 03000202 A3 WO03000202 A3 WO 03000202A3
Authority
WO
WIPO (PCT)
Prior art keywords
particles
formulations
bioactive agent
inhalation
release properties
Prior art date
Application number
PCT/US2002/020280
Other languages
French (fr)
Other versions
WO2003000202A2 (en
Inventor
Jennifer L Schmitke
Donghao Chen
Richard P Batycky
David A Edwards
Jeffrey S Hrkach
Original Assignee
Advanced Inhalation Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Inhalation Res Inc filed Critical Advanced Inhalation Res Inc
Priority to EP02752100A priority Critical patent/EP1404299A2/en
Priority to AU2002350606A priority patent/AU2002350606B2/en
Priority to NZ530123A priority patent/NZ530123A/en
Priority to CA002449439A priority patent/CA2449439A1/en
Priority to IL15898702A priority patent/IL158987A0/en
Priority to JP2003506648A priority patent/JP4067047B2/en
Priority to MXPA03011861A priority patent/MXPA03011861A/en
Publication of WO2003000202A2 publication Critical patent/WO2003000202A2/en
Publication of WO2003000202A3 publication Critical patent/WO2003000202A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

The invention generally relates to formulations having particles comprising phospholipids, bioactive agent and excipients and the pulmonary delivery thereof. Dry powder inhaled insulin formulations are disclosed. Improved formulations comprising DPPC, insulin and sodium citrate which are useful in the treatment of diabetes are disclosed. Also, the invention relates to a method of for the pulmonary delivery of a bioactive agent comprising administering to the respiratory tract of a patient in need of treatment, or diagnosis an effective amount of particles comprising a bioactive agent of any combination thereof in association, wherein release of the agent from the administered particles occurs in a rapid fashion.
PCT/US2002/020280 2000-12-29 2002-06-24 Particles for inhalation having rapid release properties WO2003000202A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
EP02752100A EP1404299A2 (en) 2001-06-22 2002-06-24 Particles for inhalation having rapid release properties
AU2002350606A AU2002350606B2 (en) 2000-12-29 2002-06-24 Particles for inhalation having rapid release properties
NZ530123A NZ530123A (en) 2001-06-22 2002-06-24 Particles comprising DPPC, insulin, sodium citrate and optionally an amino acid in a composition for inhalation that has rapid release properties
CA002449439A CA2449439A1 (en) 2001-06-22 2002-06-24 Particles for inhalation having rapid release properties
IL15898702A IL158987A0 (en) 2001-06-22 2002-06-24 Particles for inhalation having rapid release properties
JP2003506648A JP4067047B2 (en) 2001-06-22 2002-06-24 Inhalable particles with rapid release characteristics
MXPA03011861A MXPA03011861A (en) 2001-06-22 2002-06-24 Particles for inhalation having rapid release properties.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/888,126 2001-06-22
US09/888,126 US20020141946A1 (en) 2000-12-29 2001-06-22 Particles for inhalation having rapid release properties

Publications (2)

Publication Number Publication Date
WO2003000202A2 WO2003000202A2 (en) 2003-01-03
WO2003000202A3 true WO2003000202A3 (en) 2003-08-14

Family

ID=25392579

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/020280 WO2003000202A2 (en) 2000-12-29 2002-06-24 Particles for inhalation having rapid release properties

Country Status (10)

Country Link
US (3) US20020141946A1 (en)
EP (1) EP1404299A2 (en)
JP (1) JP4067047B2 (en)
CN (1) CN1518441A (en)
CA (1) CA2449439A1 (en)
IL (1) IL158987A0 (en)
MX (1) MXPA03011861A (en)
NZ (1) NZ530123A (en)
PL (1) PL367399A1 (en)
WO (1) WO2003000202A2 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8936813B2 (en) 2001-11-01 2015-01-20 Novartis Ag Spray drying methods and related compositions
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9346766B2 (en) 2004-08-20 2016-05-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9993555B2 (en) 2014-12-16 2018-06-12 Eli Lilly And Company Rapid-acting insulin compositions

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060171899A1 (en) * 1998-12-10 2006-08-03 Akwete Adjei Water-stabilized aerosol formulation system and method of making
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US8337816B2 (en) * 2001-09-17 2012-12-25 Glaxo Group Limited Dry powder medicament formulations
US7008644B2 (en) 2002-03-20 2006-03-07 Advanced Inhalation Research, Inc. Method and apparatus for producing dry particles
WO2003080149A2 (en) 2002-03-20 2003-10-02 Mannkind Corporation Inhalation apparatus
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
US7862834B2 (en) * 2003-05-28 2011-01-04 Novartis Pharma Ag Pharmaceutical formulation comprising a water-insoluble active agent
EP1667633A4 (en) * 2003-10-01 2008-10-08 Momenta Pharmaceuticals Inc Polysaccharides for pulmonary delivery of active agents
WO2005034915A2 (en) * 2003-10-03 2005-04-21 Alza Corporation Screening method for evaluation of bilayer-drug interaction in liposomal compositions
JP2007522149A (en) * 2004-02-10 2007-08-09 アドバンスト インハレーション リサーチ，インコーポレイテッド Particles for inhalation with fast release characteristics
US20070123449A1 (en) * 2005-11-01 2007-05-31 Advanced Inhalation Research, Inc. High load particles for inhalation having rapid release properties
US20070172430A1 (en) * 2006-01-20 2007-07-26 Nastech Pharmaceutical Company Inc. Dry powder compositions for rna influenza therapeutics
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
TWI494123B (en) 2008-08-11 2015-08-01 Mannkind Corp Use of ultrarapid acting insulin
CN104707130A (en) * 2008-08-15 2015-06-17 阿索尔达治疗公司 Compositions and methods for treatment during non-acute periods following cns neurological injury
CA2754595C (en) 2009-03-11 2017-06-27 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
EP2410981B2 (en) 2009-03-26 2020-02-26 Pulmatrix Operating Company, Inc. Dry powder formulations and methods for treating pulmonary diseases
US9018190B2 (en) 2009-03-27 2015-04-28 Adocia Functionalized oligosaccharides
FR2943538B1 (en) 2009-03-27 2011-05-20 Adocia QUICK ACTION FORMULATION OF RECOMBINANT HUMAN INSULIN
EP2435023B1 (en) * 2009-05-29 2016-07-06 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting beta 2 adrenergic receptor agonists and associated methods and systems
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
WO2010144789A2 (en) 2009-06-12 2010-12-16 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
GB0918450D0 (en) * 2009-10-21 2009-12-09 Innovata Ltd Composition
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
US9061352B2 (en) 2010-08-30 2015-06-23 Pulmatrix, Inc. Dry powder formulations and methods for treating pulmonary diseases
PT3470057T (en) 2010-09-29 2021-12-03 Pulmatrix Operating Co Inc Cationic dry powders comprising magnesium salt
RU2017144619A (en) 2010-09-29 2019-02-20 Пулмэтрикс, Инк. CASES OF SINGLE-VALVE METALS OF DRY POWDERS FOR INHALATIONS
US8485285B2 (en) * 2011-03-22 2013-07-16 Max Ferrigni Mobile product retail system and methods thereof
CN105667994B (en) 2011-04-01 2018-04-06 曼金德公司 Blister package for pharmaceutical kit
WO2012145603A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
CN103608743B (en) * 2011-06-17 2017-06-27 万国卡车知识产权有限公司 For the supervisory control system of hybrid electric powertrain
US20130231281A1 (en) 2011-11-02 2013-09-05 Adocia Rapid acting insulin formulation comprising an oligosaccharide
US20150136130A1 (en) * 2012-02-29 2015-05-21 Pulmatrix, Inc. Inhalable dry powders
US8988037B1 (en) * 2012-04-06 2015-03-24 The United States Of America As Represented By The Secretary Of The Navy Solar panel storage and deployment system
DK2872205T3 (en) 2012-07-12 2017-02-27 Mannkind Corp DRY POWDER FORMAL ADMINISTRATION SYSTEM
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
JP6322642B2 (en) 2012-11-13 2018-05-09 アドシア Fast-acting insulin preparation containing a substituted anionic compound
AU2014228414B2 (en) 2013-03-15 2018-09-13 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
KR102499439B1 (en) 2013-03-15 2023-02-13 맨카인드 코포레이션 Microcrystalline diketopiperazine compositions and methods
CA2907566C (en) 2013-04-01 2023-08-22 Pulmatrix, Inc. Tiotropium dry powders
WO2015010092A1 (en) 2013-07-18 2015-01-22 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
JP2016530930A (en) 2013-08-05 2016-10-06 マンカインド コーポレイション Ventilation device and method
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US9795678B2 (en) 2014-05-14 2017-10-24 Adocia Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
FR3020947B1 (en) 2014-05-14 2018-08-31 Adocia AQUEOUS COMPOSITION COMPRISING AT LEAST ONE PROTEIN AND A SOLUBILIZING AGENT, ITS PREPARATION AND ITS USES
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
DE102015004119A1 (en) * 2015-03-31 2016-10-06 Audi Ag Motor vehicle with an electrical energy storage and two charging interfaces, charging system and method
JO3749B1 (en) 2015-08-27 2021-01-31 Lilly Co Eli Rapid-acting insulin compositions
US20180303753A1 (en) * 2015-09-09 2018-10-25 Keith Try Ung Targeted delivery of spray-dried formulations to the lungs
FR3043557B1 (en) 2015-11-16 2019-05-31 Adocia RAPID ACID COMPOSITION OF INSULIN COMPRISING A SUBSTITUTED CITRATE
US10516189B2 (en) * 2016-11-15 2019-12-24 Ford Global Technologies, Llc High voltage bus contactor fault detection
MX2019014195A (en) 2017-06-01 2020-01-27 Lilly Co Eli Rapid-acting insulin compositions.
AU2018392458A1 (en) * 2017-12-21 2020-07-02 Civitas Therapeutics, Inc. Surfactant formulations for inhalation
DE102021201828A1 (en) 2021-02-26 2022-09-01 Siemens Mobility GmbH Energy supply arrangement and method, in particular for the energy supply of electrically operated vehicles, for example rail vehicles and electrically operated vehicles, in particular rail vehicles

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673567A (en) * 1984-08-16 1987-06-16 Shionogi & Co., Ltd. Process for preparing liposome composition
WO1995000127A1 (en) * 1993-06-24 1995-01-05 Astra Aktiebolag Therapeutic preparation for inhalation
US5997848A (en) * 1994-03-07 1999-12-07 Inhale Therapeutic Systems Methods and compositions for pulmonary delivery of insulin

Family Cites Families (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2470296A (en) * 1948-04-30 1949-05-17 Abbott Lab Inhalator
US2992645A (en) * 1958-05-06 1961-07-18 Benger Lab Ltd Disperser for powders
US3957965A (en) * 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
GB1410588A (en) * 1971-08-10 1975-10-22 Fisons Ltd Composition
US4069819A (en) * 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
US4089800A (en) * 1975-04-04 1978-05-16 Ppg Industries, Inc. Method of preparing microcapsules
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
US4272398A (en) * 1978-08-17 1981-06-09 The United States Of America As Represented By The Secretary Of Agriculture Microencapsulation process
US4743545A (en) * 1984-08-09 1988-05-10 Torobin Leonard B Hollow porous microspheres containing biocatalyst
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4391909A (en) * 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
ATE23272T1 (en) * 1981-07-08 1986-11-15 Draco Ab POWDER INHALER.
DE3268533D1 (en) * 1981-07-24 1986-02-27 Fisons Plc Inhalation drugs, methods for their production and pharmaceutical formulations containing them
DE3141641A1 (en) * 1981-10-16 1983-04-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen ULTRASONIC CONTRAST AGENTS AND THEIR PRODUCTION
US4480041A (en) * 1982-07-09 1984-10-30 Collaborative Research, Inc. Use of phosphotriester intermediates for preparation of functionalized liposomes
US4592436A (en) * 1982-08-19 1986-06-03 Tomei Edmardo J Solar powered vehicle
US4572203A (en) * 1983-01-27 1986-02-25 Feinstein Steven B Contact agents for ultrasonic imaging
US4718433A (en) * 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
AU565354B2 (en) * 1983-11-14 1987-09-10 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
US4818542A (en) * 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
US4865789A (en) * 1983-11-14 1989-09-12 Akzo Nv Method for making porous structures
US4679555A (en) * 1984-08-07 1987-07-14 Key Pharmaceuticals, Inc. Method and apparatus for intrapulmonary delivery of heparin
US5340587A (en) * 1985-05-22 1994-08-23 Liposome Technology, Inc. Liposome/bronchodilator method & System
JPS63500175A (en) * 1985-05-22 1988-01-21 リポソ−ム　テクノロジ−，インコ−ポレイテツド Liposome inhalation method and inhalation system
WO1987003197A1 (en) * 1985-11-29 1987-06-04 Fisons Plc Pharmaceutical composition including sodium cromoglycate
GB8601100D0 (en) * 1986-01-17 1986-02-19 Cosmas Damian Ltd Drug delivery system
US4741872A (en) * 1986-05-16 1988-05-03 The University Of Kentucky Research Foundation Preparation of biodegradable microspheres useful as carriers for macromolecules
ES2053549T3 (en) * 1986-08-11 1994-08-01 Innovata Biomed Ltd A PROCESS FOR THE PREPARATION OF AN APPROPRIATE PHARMACEUTICAL FORMULATION FOR INHALATION.
DE3637926C1 (en) * 1986-11-05 1987-11-26 Schering Ag Ultrasonic manometry in a liquid using microbubbles
JPS63122620A (en) * 1986-11-12 1988-05-26 Sanraku Inc Polylactic acid microsphere and production thereof
US4963297A (en) * 1987-12-22 1990-10-16 The Liposome Company, Inc. Spontaneous vesticulation of multilamellar liposomes
US5204113A (en) * 1987-04-09 1993-04-20 Fisons Plc Pharmaceutical compositions containing pentamidine
US4861627A (en) * 1987-05-01 1989-08-29 Massachusetts Institute Of Technology Preparation of multiwall polymeric microcapsules
US4857311A (en) * 1987-07-31 1989-08-15 Massachusetts Institute Of Technology Polyanhydrides with improved hydrolytic degradation properties
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
US4855144A (en) * 1987-10-23 1989-08-08 Advanced Polymer Systems Synthetic melanin aggregates
JP2670680B2 (en) * 1988-02-24 1997-10-29 株式会社ビーエムジー Polylactic acid microspheres containing physiologically active substance and method for producing the same
US4917119A (en) * 1988-11-30 1990-04-17 R. J. Reynolds Tobacco Company Drug delivery article
IT1228459B (en) * 1989-02-23 1991-06-19 Phidea S R L INHALER WITH REGULAR AND COMPLETE EMPTYING OF THE CAPSULE.
DE69024953T3 (en) * 1989-05-04 2005-01-27 Southern Research Institute, Birmingham encapsulation
US5176132A (en) * 1989-05-31 1993-01-05 Fisons Plc Medicament inhalation device and formulation
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
IT1237118B (en) * 1989-10-27 1993-05-18 Miat Spa MULTI-DOSE INHALER FOR POWDER DRUGS.
US5707644A (en) * 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
US5334381A (en) * 1989-12-22 1994-08-02 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5123414A (en) * 1989-12-22 1992-06-23 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5352435A (en) * 1989-12-22 1994-10-04 Unger Evan C Ionophore containing liposomes for ultrasound imaging
SE9002017D0 (en) * 1990-06-06 1990-06-06 Kabivitrum Ab PROCESS FOR MANUFACTURE OF MATRICES
US5614216A (en) * 1990-10-17 1997-03-25 The Liposome Company, Inc. Synthetic lung surfactant
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
SE9302777D0 (en) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
US5327883A (en) * 1991-05-20 1994-07-12 Dura Pharmaceuticals, Inc. Apparatus for aerosolizing powdered medicine and process and using
AU659645B2 (en) * 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
PT679088E (en) * 1992-09-29 2002-12-31 Inhale Therapeutic Syst PULMONARY ADMINISTRATION OF ACTIVE FRAGMENTS OF PARTIROID HORMONE
SE9203743D0 (en) * 1992-12-11 1992-12-11 Astra Ab EFFICIENT USE
US5698721A (en) * 1992-12-17 1997-12-16 Megabios Corporation Catonic amphiphiles
US5603945A (en) * 1993-02-19 1997-02-18 Takeda Chemical Industries, Ltd. Therapeutic/prophylactic agents and method of treating for urinary calculosis in pets
SE9301220D0 (en) * 1993-04-14 1993-04-14 Kabi Pharmacia Ab MANUFACTURING MATRICES
US5506203C1 (en) * 1993-06-24 2001-02-06 Astra Ab Systemic administration of a therapeutic preparation
GB9313650D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
ATE209903T1 (en) * 1993-10-01 2001-12-15 Astrazeneca Ab PROCEDURE I
GB9322014D0 (en) * 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US6051256A (en) * 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
CN1073119C (en) * 1994-05-18 2001-10-17 吸入治疗系统公司 Method and compositions for the dry powder formulation of interferons
GB9413202D0 (en) * 1994-06-30 1994-08-24 Univ Bradford Method and apparatus for the formation of particles
GB9413605D0 (en) * 1994-07-06 1994-08-24 American Colloid Co Method of increasing the size and absorption under load of super-absorbent fine particles by impregnation with an aqueous acrylic monomer solution
US5486569A (en) * 1994-09-28 1996-01-23 American Colloid Company Method of increasing the size and/or absorption under load of superabsorbent polymers by surface cross-linking and subsequent agglomeration of undersized particcles
US5885613A (en) * 1994-09-30 1999-03-23 The University Of British Columbia Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
US5648101A (en) * 1994-11-14 1997-07-15 Tawashi; Rashad Drug delivery of nitric oxide
SA95160463B1 (en) * 1994-12-22 2005-10-04 استرا أكتيبولاج powders for inhalation
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
US6136346A (en) * 1995-04-14 2000-10-24 Inhale Therapeutic Systems Powdered pharmaceutical formulations having improved dispersibility
US6258341B1 (en) * 1995-04-14 2001-07-10 Inhale Therapeutic Systems, Inc. Stable glassy state powder formulations
US5780014A (en) * 1995-04-14 1998-07-14 Inhale Therapeutic Systems Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin
US6019968A (en) * 1995-04-14 2000-02-01 Inhale Therapeutic Systems, Inc. Dispersible antibody compositions and methods for their preparation and use
US5637980A (en) * 1995-05-08 1997-06-10 Wu; Jimmy Battery charging/discharging switching control protective circuit
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
USRE37053E1 (en) * 1996-05-24 2001-02-13 Massachusetts Institute Of Technology Particles incorporating surfactants for pulmonary drug delivery
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5855913A (en) * 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US6103270A (en) * 1996-06-07 2000-08-15 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
US6096291A (en) * 1996-12-27 2000-08-01 Biovector Therapeutics, S.A. Mucosal administration of substances to mammals
WO1998029098A1 (en) * 1996-12-31 1998-07-09 Inhale Therapeutic Systems, Inc. Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
SE9700133D0 (en) * 1997-01-20 1997-01-20 Astra Ab New formulation
US5911941A (en) * 1997-04-10 1999-06-15 Nucon Systems Process for the preparation of thick-walled ceramic products
US6433040B1 (en) * 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
AU2484399A (en) * 1998-01-30 1999-08-16 Scios Inc. Controlled release delivery of peptide or protein
KR20010042531A (en) * 1998-04-08 2001-05-25 피터 지. 스트링거 Pulmonary and Nasal Delivery of Raloxifene
US5986429A (en) * 1998-06-29 1999-11-16 Mula, Jr.; John Battery charging system for electric vehicles
US6586668B2 (en) * 1999-02-05 2003-07-01 Powerlight Corporation Electric vehicle with photovoltaic roof assembly
DE19937221C1 (en) * 1999-08-06 2000-09-07 Webasto Dachsysteme Gmbh Solar vehicle roof has additional element with additional solar generator for coupling to closure element in open position so additional element adopts working position on vehicle exterior
US6227601B1 (en) * 2000-03-20 2001-05-08 Lafrance Joseph E. Motor driven sunshield
US6735645B1 (en) * 2001-09-04 2004-05-11 Lsi Logic Corporation System and method to eliminate race conditions in input/output operations for high bandwidth architectures
US6617822B1 (en) * 2001-09-12 2003-09-09 Bellsouth Intellectual Property Corporation System and method to maintain charge of vehicle battery using light energy
US20040201244A1 (en) * 2002-12-31 2004-10-14 Leon Neuer Automobile sunshade
US7140662B1 (en) * 2003-10-06 2006-11-28 Wilkinson Kari L Retractable sunshade
US7718923B1 (en) * 2007-02-09 2010-05-18 Hansen Scott P Defrosting windshield sunshade panel

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673567A (en) * 1984-08-16 1987-06-16 Shionogi & Co., Ltd. Process for preparing liposome composition
WO1995000127A1 (en) * 1993-06-24 1995-01-05 Astra Aktiebolag Therapeutic preparation for inhalation
US5997848A (en) * 1994-03-07 1999-12-07 Inhale Therapeutic Systems Methods and compositions for pulmonary delivery of insulin

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8936813B2 (en) 2001-11-01 2015-01-20 Novartis Ag Spray drying methods and related compositions
US9346766B2 (en) 2004-08-20 2016-05-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9446001B2 (en) 2005-09-14 2016-09-20 Mannkind Corporation Increasing drug affinity for crystalline microparticle surfaces
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9511198B2 (en) 2008-06-13 2016-12-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9339615B2 (en) 2008-06-13 2016-05-17 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9446133B2 (en) 2008-06-13 2016-09-20 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9655850B2 (en) 2008-12-29 2017-05-23 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9993555B2 (en) 2014-12-16 2018-06-12 Eli Lilly And Company Rapid-acting insulin compositions

Also Published As

Publication number Publication date
PL367399A1 (en) 2005-02-21
JP2005500309A (en) 2005-01-06
IL158987A0 (en) 2004-05-12
US20100026235A1 (en) 2010-02-04
WO2003000202A2 (en) 2003-01-03
EP1404299A2 (en) 2004-04-07
NZ530123A (en) 2007-01-26
US20080227690A1 (en) 2008-09-18
CA2449439A1 (en) 2003-01-03
MXPA03011861A (en) 2004-03-26
JP4067047B2 (en) 2008-03-26
CN1518441A (en) 2004-08-04
US20020141946A1 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
WO2003000202A3 (en) Particles for inhalation having rapid release properties
US6616914B2 (en) Method for pulmonary and oral delivery of pharmaceuticals
WO2002053190A3 (en) Particles for inhalation having sustained release properties
WO2002078675A3 (en) Particles for inhalation having sustained release properties
EP1911481A2 (en) Methods and systems of delivering medication via inhalation
TNSN06277A1 (en) Pharmaceutical formulations for dry powder inhalers comprising a low-dosage strength active ingredient
EP1938814A4 (en) Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis
CA2478980A1 (en) Pulmonary delivery for levodopa
CA2421974A1 (en) Pulmonary delivery in treating disorders of the central nervous system
CN101553210A (en) Methods and systems of delivering medication via inhalation
JP2007520506A5 (en)
YU36302A (en) Novel tiotropium preparation -containing inhalation powder
RU2007124795A (en) MEDICAL PRODUCT CONTAINING A MEDICINE BASED ON A GLUCAGON-LIKE PEPTIDE, INTENDED FOR PULMONARY INHALATION
WO2005089448A3 (en) Administration of cisplatin by inhalation
JP2007520507A5 (en)
JP4437040B2 (en) Aerosolization device with connectable body and end piece
KR20230111206A (en) Composition for treating vascular disease, composition for preventing vascular disease, composition for treating hypertension, and composition for preventing hypertension
HK1078795A1 (en) Powder formulations suitable for inhalation
JP2016528958A (en) Oral drug delivery device and method of using the oral drug delivery device
WO2005077338A8 (en) Particles for inhalation rapid release properties
WO2007053729A3 (en) High load particles for inhalation having rapid release properties
KR101516057B1 (en) Inhalant formulation for treatment of pulmonary diseases and preparaton method thereof
JP2023551989A (en) Product delivery devices and methods
BR0316343A (en) Tiotropium inhalation powder formulations
JP6818924B1 (en) Method for improving nontuberculous mycobacteriosis using slaked lime

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 158987

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2449439

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002350606

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 530123

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2002752100

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: PA/a/2003/011861

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2003506648

Country of ref document: JP

Ref document number: 028125665

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2002752100

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642